These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1551745)

  • 21. [A clinical experience of ofloxacin in patients with respiratory infection].
    Tanaka K; Suzuki H; Shimizu S; Otsuka H; Takagi H; Akisawa T; Narushima M; Tonotsuka H; Kaneshige H; Nakagami K
    Jpn J Antibiot; 1989 Aug; 42(8):1705-12. PubMed ID: 2810733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of ofloxacin in complicated urinary tract infection].
    Akazawa N; Tsugawa M; Hayata S; Sasaki H; Asahi T; Okita K
    Hinyokika Kiyo; 1988 Jul; 34(7):1279-82. PubMed ID: 3177148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and tissue distribution of ofloxacin in human subjects during a multiple dose regimen.
    De Bernardis E; Bonaccorsi S; Carlino S; Picari M; Rizza V
    Int J Clin Pharmacol Res; 1988; 8(4):239-45. PubMed ID: 3182113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cefotiam in plasma, parotid saliva and mixed saliva in healthy adults.
    Zerfowski M; Schlegel P; Maier H
    Arzneimittelforschung; 1991 Mar; 41(3):257-9. PubMed ID: 1867664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ofloxacin. An overview.
    Flor S
    Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
    Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis.
    Tsaganos T; Kouki P; Digenis P; Giamarellou H; Giamarellos-Bourboulis EJ; Kanellakopoulou K
    Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antituberculosis effect of levofloxacin].
    Lu Y; Zhu L; Duan L
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):50-4. PubMed ID: 11778184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time course of free and N4-acetylated sulfapyridine concentrations in the plasma and saliva of man after sulfasalazine (salicylazosulfapyridine) administration: preliminary findings.
    Bates TR; Blumenthal HP; Pieniaszek HJ
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):183-9. PubMed ID: 9675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantioselective disposition of ofloxacin in humans.
    Okazaki O; Kojima C; Hakusui H; Nakashima M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2106-9. PubMed ID: 1759834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-linear pharmacokinetics of ofloxacin after a single intravenous bolus dose in pigs.
    Son DS; Ikenoue N; Tagawa Y; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2000 Oct; 23(5):311-5. PubMed ID: 11107005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ofloxacin concentrations in tissues involved in respiratory tract infections.
    Perea EJ
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():55-60. PubMed ID: 2286591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ofloxacin as a reference marker in hair of various colors.
    Wilkins DG; Mizuno A; Borges CR; Slawson MH; Rollins DE
    J Anal Toxicol; 2003 Apr; 27(3):149-55. PubMed ID: 12731656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aluminium-containing antacid on bioavailability of ofloxacin following oral administration of pivaloyloxymethyl ester of ofloxacin as prodrug.
    Maeda Y; Omoda K; Konishi T; Takahashi M; Kihira K; Hibino S; Tsukiai S
    Biol Pharm Bull; 1993 Jun; 16(6):594-9. PubMed ID: 8364513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint].
    Fujita A; Miya T; Tanaka R; Hirayama S; Isaka H; Ono Y; Koshiishi Y; Goya T
    Jpn J Antibiot; 1999 Nov; 52(11):661-6. PubMed ID: 10659442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experience with ofloxacin in the treatment of chronic respiratory tract disease aggravated by acute infection].
    Muraki N; Chen RM; Kakusaka I; Kuriyama T; Kanno H; Kikuchi N; Suzuki K; Yamagishi F; Yamamoto T; Watanabe S
    Jpn J Antibiot; 1988 Sep; 41(9):1231-6. PubMed ID: 3149326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselective metabolic disposition of enantiomers of ofloxacin in rats.
    Okazaki O; Kurata T; Tachizawa H
    Xenobiotica; 1989 Apr; 19(4):419-29. PubMed ID: 2501940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.
    Warlich R; Korting HC; Schäfer-Korting M; Mutschler E
    Antimicrob Agents Chemother; 1990 Jan; 34(1):78-81. PubMed ID: 2327762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.